{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:endothelin-receptor-antagonists",
  "owner": "cardio",
  "kind": "drug",
  "slug": "endothelin-receptor-antagonists",
  "name": "Endothelin receptor antagonists",
  "aliases": [
    "Endothelin Receptor Antagonist",
    "Endothelin Antagonists",
    "ERA"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "Endothelin receptor antagonists are medicines that block the receptors for endothelin-1, a peptide that acts on blood vessels. MeSH describes the group as compounds and drugs that bind to and block the activation of endothelin receptors. The US labels of Tracleer (bosentan), Letairis (ambrisentan) and Opsumit (macitentan) each call the product an endothelin receptor antagonist indicated for pulmonary arterial hypertension, and each medicine has its own page. This is the class page: what each medicine has been shown to do, and its warnings, sit on its own page.",
  "summary_technical": "Class page. MeSH descriptor D065128 (Endothelin Receptor Antagonists, lastUpdated 2020-05-27) is an exact match; its scope note says these are compounds and drugs that bind to and inhibit or block the activation of endothelin receptors. RxClass lists, for each of bosentan, ambrisentan and macitentan, the established pharmacologic class on US drug labels Endothelin Receptor Antagonist (EPC) and the mechanism-of-action class Endothelin Receptor Antagonists (read 2026-11-18); the three medicines are filed under this page on that evidence. The Letairis label says endothelin-1 acts through two receptor subtypes, ET A and ET B, in vascular smooth muscle and the endothelium. The combination product that pairs macitentan with tadalafil was not read. No trial result, dose or instruction is recorded.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-18",
  "last_evidence_check": "2026-11-18",
  "next_review_due": "2027-05-18",
  "identifiers": [
    {
      "scheme": "mesh",
      "value": "D065128",
      "normalized_value": "D065128",
      "match": "exact",
      "version": "id.nlm.nih.gov linked data, retrieved 2026-11-18",
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "blood-vessels",
        "heart"
      ],
      "condition-area": [
        "coronary-and-vascular-disease"
      ]
    }
  },
  "payload": {
    "level": "class",
    "mechanism": "MeSH says these compounds and drugs bind to and block the activation of endothelin receptors; the Letairis label says endothelin-1 acts through the ET A and ET B receptor subtypes in the vascular smooth muscle and endothelium."
  },
  "content_digest": "a83cb07c27e21b500fd5be00ff2d5a6d5c57edf1b393d634c3409c7dff9b0101",
  "review": {
    "content_digest": "a83cb07c27e21b500fd5be00ff2d5a6d5c57edf1b393d634c3409c7dff9b0101",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "The US labels of the member medicines list pulmonary arterial hypertension as the indication",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:pulmonary-arterial-hypertension",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Pulmonary arterial hypertension is one type of pulmonary hypertension",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:pulmonary-hypertension",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "A separate US product combines an endothelin receptor antagonist, macitentan, with tadalafil, according to its label",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:tadalafil",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ambrisentan",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-358274-2026-11-18",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:bosentan",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-75207-2026-11-18",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:macitentan",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-1442132-2026-11-18",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/endothelin-receptor-antagonists/",
  "context_path": "api/v1/context/cardio--endothelin-receptor-antagonists.md"
}
